/Companies

Dname-iT

2 known investors

Find your way into Dname-iT

Sign up to see every warm intro you have to Dname-iT

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Dname-iT team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

DName-iT, a KU Leuven spin-off, has developed a DNA-based barcode labelling technology and software platform (DNames™) that tracks and identifies next-generation sequencing (NGS) specimens to detect handling errors. It serves clinical laboratories and the liquid biopsy, clinical trials and NGS markets, with an initial focus on non-invasive prenatal testing and later cancer therapy selection.

Founders & leadership

HC
Harry CuppensFounder & CSO

Investors · 2

Also in the syndicate · 1

Gemma Frisius Fund

In the news

Frequently asked questions

What does Dname-iT do?
DName-iT, a KU Leuven spin-off, has developed a DNA-based barcode labelling technology and software platform (DNames™) that tracks and identifies next-generation sequencing (NGS) specimens to detect handling errors. It serves clinical laboratories and the liquid biopsy, clinical trials and NGS markets, with an initial focus on non-invasive prenatal testing and later cancer therapy selection.
Who are Dname-iT's investors?
Dname-iT's investors include EMV Capital.